Legend Biotech is poised to enhance its cell therapy research and development capabilities with the establishment of a new R&D site in Philadelphia’s Center City district. Scheduled to open by the third quarter of 2025, the 31,000-square-foot facility will employ around 55 full-time workers and be dedicated to developing next-generation cell therapies. This strategic expansion complements the company’s current R&D operations located in Piscataway, New Jersey. Situated in close proximity to top-tier academic institutions such as the University of Pennsylvania and Drexel University, the new facility promises to foster collaborations and provide access to the latest cutting-edge research.
Guowei Fang, Ph.D., Legend’s chief scientific officer, emphasized that the new facility offers an optimal environment replete with essential resources for innovative research and development. The site has been developed by Breakthrough Properties, which features Philadelphia’s significant role in securing National Institutes of Health (NIH) grant funding for cell and gene therapy initiatives. Fang remarked on the unique opportunities afforded by the new location, highlighting the advantages of being near eminent academic researchers and institutions dedicated to scientific advancement.
Strategic Collaborations and Innovation
Legend Biotech is set to bolster its cell therapy research and development with a new R&D center in Philadelphia’s Center City district. Slated to open by the third quarter of 2025, this 31,000-square-foot facility will employ approximately 55 full-time staff and focus on next-generation cell therapies. This strategic move complements the company’s existing R&D operations in Piscataway, New Jersey. The new site’s location is advantageous, close to leading academic institutions such as the University of Pennsylvania and Drexel University, which will facilitate collaborations and provide access to cutting-edge research.
Guowei Fang, Ph.D., the chief scientific officer at Legend, emphasized that the new Philadelphia facility will offer an optimal setting filled with the necessary resources for groundbreaking research and development. The site is being developed by Breakthrough Properties and underscores Philadelphia’s pivotal role in securing NIH funding for cell and gene therapy projects. Fang pointed out the unique benefits of being close to renowned academic researchers and institutions that are committed to scientific advancement, thus enhancing Legend Biotech’s innovation potential.
